PACS — PACS Group, Inc. Stock Price, Chart & AI Report

Positive Dec 9, 2025 • 18:05 UTC The Motley Fool • Cory Renauer

A PACS Group Insider Acquired 16,724 Shares for $500,000

Evelyn Dilsaver, a PACS Group director, purchased 16,724 shares worth $500,000 on November 24, 2025, increasing her direct ownership by 278%. The purchase suggests confidence in the company's strong financial performance and growth potential.

PACS insider trading healthcare services post-acute care stock purchase

Sentiment note

Strong financial performance with 31.4% sales growth in 2024, 36.4% revenue increase in first nine months of 2025, high 94.8% occupancy rate, and insider confidence demonstrated by significant share purchase

Negative Jan 13, 2025 • 23:54 UTC GlobeNewswire Inc. • N/A

PACS Group, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. January 13, 2025 Deadline to file Lead Plaintiff Motion

PACS Group, Inc. is accused of engaging in fraudulent practices, including exploiting taxpayer-funded healthcare programs and improperly billing Medicare. This has resulted in a significant drop in the company's stock price, leading to losses for investors.

PACS PACS Group Hindenburg Research Medicare

Sentiment note

The article reports that PACS Group is accused of engaging in fraudulent practices, which has led to a significant drop in the company's stock price and losses for investors.

Negative Jan 13, 2025 • 19:43 UTC GlobeNewswire Inc. • N/A

PACS DEADLINE TODAY: ROSEN, A LEADING NATIONAL FIRM, Encourages PACS Group Inc. Investors to Secure Counsel Before Important January 13 Deadline in Securities Class Action - PACS

PACS Group Inc. is facing a securities class action lawsuit alleging the company engaged in a scheme to submit false Medicare claims and bill unnecessary therapies. The lawsuit claims investors suffered damages as a result of the company's misleading statements.

PACS PACS Group Inc. securities class action Medicare fraud false claims

Sentiment note

The article alleges that PACS Group Inc. engaged in a scheme to submit false Medicare claims and bill unnecessary therapies, which led to misleading statements and caused damages to investors.

Negative Jan 13, 2025 • 03:55 UTC GlobeNewswire Inc. • The Schall Law Firm

PACS Investors Have Opportunity to Lead PACS Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PACS Group, Inc. is facing a class action lawsuit for securities fraud related to false Medicare claims and falsified documentation. Investors who purchased the company's securities during the IPO or class period are encouraged to join the lawsuit to recover their losses.

PACS PACS Group, Inc. securities fraud class action lawsuit Medicare claims falsified documentation

Sentiment note

The article alleges that PACS Group, Inc. engaged in a false Medicare claim scam and falsified documentation, leading to a securities fraud lawsuit. This suggests the company's actions were unethical and harmful to investors.

Negative Jan 12, 2025 • 13:36 UTC GlobeNewswire Inc. • N/A

DEADLINE TOMORROW: Berger Montague Advises PACS Group (NYSE: PACS) Investors to Inquire About a Securities Fraud Class Action by January 13, 2025

PACS Group, a skilled nursing and post-acute care facility operator, is facing a securities fraud class action lawsuit. The lawsuit alleges that PACS inflated its Medicare revenues by misclassifying patients and fraudulently billing for unnecessary treatments and services.

PACS PACS Group securities fraud class action lawsuit Medicare reimbursement

Sentiment note

The article reports that PACS is facing a securities fraud class action lawsuit, alleging that the company inflated its Medicare revenues through improper patient classification and fraudulent billing practices. This suggests a negative sentiment towards PACS due to the alleged misconduct.

Negative Jan 11, 2025 • 18:19 UTC GlobeNewswire Inc. • N/A

Medicare Fraud Allegations Cast Shadow Over PACS Group (PACS) – Hagens Berman

PACS Group, a nursing home operator, has experienced a 70% decline in market capitalization since early November due to allegations of deceptive Medicare billing practices, a federal regulatory investigation, and a class-action lawsuit filed by investors.

PACS PACS Group nursing home Medicare billing federal investigation investor lawsuit

Sentiment note

The article reports that PACS Group is facing serious allegations of deceptive Medicare billing practices, a federal regulatory investigation, and a burgeoning investor class-action lawsuit, which have led to a precipitous decline in the company's stock price and market capitalization.

Negative Jan 10, 2025 • 18:50 UTC GlobeNewswire Inc. • N/A

PACS DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages PACS Group Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important January 13 Deadline in Securities Class Action - PACS

PACS Group Inc. is facing a securities class action lawsuit for allegedly making false and misleading statements about its business practices, which led to investor losses. The Rosen Law Firm is encouraging affected investors to secure counsel before the January 13, 2025 deadline.

PACS PACS Group Inc. securities class action Rosen Law Firm

Sentiment note

The article alleges that PACS Group Inc. engaged in a scheme to submit false Medicare claims and bill for unnecessary therapies, which led to investor losses. This suggests the company's business practices were unethical and misleading, resulting in a negative sentiment.

Negative Jan 9, 2025 • 19:27 UTC GlobeNewswire Inc. • N/A

PACS Deadline in 4 Days: Kessler Topaz Meltzer & Check, LLP Reminds PACS Group, Inc. (PACS) Investors of Filing Deadline in Class Action Lawsuit

A securities class action lawsuit has been filed against PACS Group, Inc. (PACS) for allegedly making materially false and misleading statements in its registration statement and during the class period, including claims of submitting false Medicare claims and engaging in other fraudulent schemes.

PACS PACS Group, Inc. securities class action lawsuit Medicare fraud

Sentiment note

The article alleges that PACS engaged in a scheme to submit false Medicare claims, bill unnecessary therapies, and falsify documentation, which led to materially misleading statements about the company's business and prospects.

Negative Jan 7, 2025 • 23:47 UTC GlobeNewswire Inc. • N/A

Investors Sue PACS Group (PACS) Amid Accusations of Medicare Fraud – Hagens Berman

PACS Group, a nursing home operator, has experienced a 70% decline in market capitalization since early November due to allegations of deceptive Medicare billing practices, a federal regulatory investigation, and a class-action lawsuit filed by investors.

PACS PACS Group nursing home Medicare billing federal investigation investor lawsuit

Sentiment note

The article reports that PACS Group is facing serious allegations of deceptive Medicare billing practices, a federal regulatory investigation, and a burgeoning investor class-action lawsuit, which have led to a precipitous decline in the company's stock price and market capitalization.

Negative Jan 7, 2025 • 19:47 UTC GlobeNewswire Inc. • N/A

PACS DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages PACS Group Inc. Investors to Secure Counsel Before Important January 13 Deadline in Securities Class Action - PACS

Rosen Law Firm is encouraging PACS Group Inc. investors to secure counsel before the January 13, 2025 deadline in a securities class action lawsuit. The lawsuit alleges that PACS engaged in a scheme to submit false Medicare claims and bill unnecessary therapies, leading to materially misleading statements about the company's business and prospects.

PACS PACS Group Inc. securities class action Medicare fraud false claims

Sentiment note

The article alleges that PACS Group Inc. engaged in a scheme to submit false Medicare claims and bill unnecessary therapies, leading to materially misleading statements about the company's business and prospects. This suggests the company's actions were unethical and potentially illegal, resulting in a negative sentiment.

Negative Jan 6, 2025 • 20:53 UTC GlobeNewswire Inc. • Kirby Mcinerney Llp

PACS INVESTOR ALERT: Kirby McInerney LLP Notifies PACS Group, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

Kirby McInerney LLP notifies PACS Group, Inc. investors of an upcoming lead plaintiff deadline in a class action lawsuit alleging the company engaged in a scheme to submit false Medicare claims and bill for unnecessary therapies, leading to a decline in the stock price.

PACS PACS Group, Inc. class action lawsuit Medicare fraud false claims

Sentiment note

The article alleges that PACS Group, Inc. engaged in a scheme to submit false Medicare claims and bill for unnecessary therapies, which led to a significant decline in the stock price. This suggests the company's actions were unethical and had a negative impact on investors.

Negative Jan 5, 2025 • 14:18 UTC GlobeNewswire Inc. • N/A

PACS LAWSUIT DEADLINE: BFA Law Alerts PACS Group Investors of Imminent January 13 Class Action Deadline – Contact the Firm if You Lost Money (NYSE:PACS)

A lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) for potential violations of federal securities laws. The lawsuit alleges that PACS's 'turnaround' strategy was driven by illicitly accessing Medicare benefits for thousands of patients.

PACS PACS Group securities lawsuit Medicare fraud

Sentiment note

The article alleges that PACS Group engaged in fraudulent practices by illicitly accessing Medicare benefits, which led to a securities lawsuit being filed against the company.